Arizona State Retirement System Zymeworks Inc. Transaction History

Arizona State Retirement System

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$4.82 - $7.7 $65,330 - $104,365	-13,554 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$6.0 - $16.98 $81,324 - $230,146	13,554 New	13,554 $89,000
Q4 2021 Feb 04, 2022	SELL	$15.19 - $29.33 $152,811 - $295,059	-10,060 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$27.35 - $37.28 $738 - $1,006	27 Added 0.27%	10,060 $292,000
Q2 2021 Aug 02, 2021	BUY	$26.5 - $38.23 $715 - $1,032	27 Added 0.27%	10,033 $348,000
Q1 2021 May 06, 2021	BUY	$29.83 - $56.81 $2,684 - $5,112	90 Added 0.91%	10,006 $316,000
Q4 2020 Jan 28, 2021	SELL	$39.12 - $54.99 $15,217 - $21,391	-389 Reduced 3.77%	9,916 $469,000
Q3 2020 Nov 05, 2020	BUY	$29.21 - $46.58 $75,887 - $121,014	2,598 Added 33.71%	10,305 $480,000
Q2 2020 Aug 04, 2020	BUY	$33.67 - $40.0 $259,494 - $308,280	7,707 New	7,707 $278,000

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $872M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

Stay updated on Arizona State Retirement System with notifications on news.